Playback speed
10 seconds
This video is featured in the 2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "BrUOG 354 Trial Final Results - Nivo vs. Nivo/Ipi for Ovarian & Other Extra-Renal Clear Cell Carcinomas"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Don Dizon
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Don Dizon
200 views
June 13, 2024
Chapters
BrUOG 354 Trial Overview & Objectives
00:00
Rationale for Immunotherapy in Clear Cell Cancers
03:29
BrUOG 354 Trial Design & Demographics
05:04
Treatment Results & Patient Case Study
08:28
Survivability Data & Final Conclusions
11:21
Comments 0
Login to view comments.
Click here to Login